Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 378

Results For "CENT"

4837 News Found

Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


USFDA approves first Covid-19 treatment for young children
Drug Approval | April 26, 2022

USFDA approves first Covid-19 treatment for young children

This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur
Clinical Trials | April 26, 2022

SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur

The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand


Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Corbevax gets DCGI nod for Emergency Use in 5-12 years
Drug Approval | April 26, 2022

Corbevax gets DCGI nod for Emergency Use in 5-12 years

The approval comes soon after Corbevax was given the nod for 12-15-year group


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


Glamyo Health records ARR of US $ 8 million last fiscal
Startup | April 25, 2022

Glamyo Health records ARR of US $ 8 million last fiscal

It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care


New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah
News | April 25, 2022

Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah

The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19